According to the node degrees in our constructed core component-target network, PTGS2, NOS2, CDK2, GSK3B, CCNA2, PPARG, MAPK14, CASP3, BCL2, and RELA were suggested as core targets of FXF for the treatment of pulmonary fibrosis. The gene discussed is NOS2; the disease is pulmonary fibrosis.